Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
adenosine
Overview
What is Adenocard?
Adenosine is an endogenous nucleoside occurring in all cells of the body. It is chemically 6-amino-9-β-D-ribofuranosyl-9-H-purine and has the following structural formula:
CHNO 267.24
Adenosine is a white crystalline powder. It is soluble in water and practically insoluble in alcohol. Solubility increases by warming and lowering the pH. Adenosine is not chemically related to other antiarrhythmic drugs. Adenocard (adenosine injection) is a sterile, nonpyrogenic solution for rapid bolus intravenous injection. Each mL contains 3 mg adenosine and 9 mg sodium chloride in Water for Injection. The pH of the solution is between 4.5 and 7.5.
The plastic syringe is molded from a specially formulated polypropylene. Water permeates from inside the container at an extremely slow rate which will have an insignificant effect on solution concentration over the expected shelf life.
Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the syringe material.
What does Adenocard look like?
What are the available doses of Adenocard?
Sorry No records found.
What should I talk to my health care provider before I take Adenocard?
Sorry No records found
How should I use Adenocard?
Intravenous Adenocard (adenosine injection) is indicated for the following.
Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to Adenocard administration.
It is important to be sure the Adenocard solution actually reaches the systemic circulation (see ).
Adenocard does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following Adenocard administration.
For rapid bolus intravenous use only.
Adenocard (adenosine injection) should be given as a rapid bolus by the peripheral intravenous route. To be certain the solution reaches the systemic circulation, it should be administered either directly into a vein or, if given into an IV line, it should be given as close to the patient as possible and followed by a rapid saline flush.
What interacts with Adenocard?
Sorry No Records found
What are the warnings of Adenocard?
Sorry No Records found
What are the precautions of Adenocard?
Sorry No Records found
What are the side effects of Adenocard?
Sorry No records found
What should I look out for while using Adenocard?
Intravenous Adenocard (adenosine injection) is contraindicated in:
What might happen if I take too much Adenocard?
The half-life of Adenocard (adenosine injection) is less than 10 seconds. Thus, adverse effects are generally rapidly self-limiting. Treatment of any prolonged adverse effects should be individualized and be directed toward the specific effect. Methylxanthines, such as caffeine and theophylline, are competitive antagonists of adenosine.
How should I store and handle Adenocard?
TROKENDI XR (topiramate) extended-release capsules should be stored in well closed containers at controlled room temperature [25°C (77°F); excursions 15°C-30°C (59°F-86°F)]. Protect from moisture and light.Adenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx OnlyAdenocard (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.NDC 0469-8234-12 Product Code 8234126 mg/2 mL (3 mg/mL) in 2 mL (fill volume) plastic disposable syringe, in a package of ten.NDC 0469-8234-14 Product Code 82341412 mg/4 mL (3 mg/mL) in 4 mL (fill volume) plastic disposable syringe, in a package of ten.Store at controlled room temperature 15º-30ºC (59º-86ºF).DO NOT REFRIGERATEContains no preservatives. Discard unused portion.May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.Rx Only
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Adenocard (adenosine injection) slows conduction time through the A-V node, can interrupt the reentry pathways through the A-V node, and can restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including PSVT associated with Wolff-Parkinson-White Syndrome.
Adenocard is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenocard is not blocked by atropine.
Non-Clinical Toxicology
Intravenous Adenocard (adenosine injection) is contraindicated in:Intravenous Adenocard (adenosine injection) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile. Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see ). Because of the potential for additive or synergistic depressant effects on the SA and AV nodes, however, Adenocard should be used with caution in the presence of these agents. The use of Adenocard in patients receiving digitalis may be rarely associated with ventricular fibrillation (see ).
The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline. In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective. Adenosine effects are potentiated by dipyridamole. Thus, smaller doses of adenosine may be effective in the presence of dipyridamole. Carbamazepine has been reported to increase the degree of heart block produced by other agents. As the primary effect of adenosine is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of carbamazepine.
Intravenous Adenocard (adenosine injection) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile. Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see ). Because of the potential for additive or synergistic depressant effects on the SA and AV nodes, however, Adenocard should be used with caution in the presence of these agents. The use of Adenocard in patients receiving digitalis may be rarely associated with ventricular fibrillation (see ).
The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline. In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective. Adenosine effects are potentiated by dipyridamole. Thus, smaller doses of adenosine may be effective in the presence of dipyridamole. Carbamazepine has been reported to increase the degree of heart block produced by other agents. As the primary effect of adenosine is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of carbamazepine.
The following reactions were reported with intravenous Adenocard (adenosine injection) used in controlled U.S. clinical trials. The placebo group had less than 1% rate of all of these reactions.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Read user comments about the side effects, benefits, and effectiveness of losartan oral.
Overall User Ratings
516Total User Reviews
User Reviews
Learn about
User Reviews
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).